Suven Pharmaceuticals Limited (SUVENPHAR.BO)
INR 1081.15
(2.68%)
INR 1081.15
(2.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 22.54 Billion INR | 14.67% |
| 2022 | 19.65 Billion INR | 7.44% |
| 2021 | 18.29 Billion INR | 24.08% |
| 2020 | 14.74 Billion INR | 25.72% |
| 2019 | 11.72 Billion INR | 49.78% |
| 2018 | 7.83 Billion INR | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 21.19 Billion INR | 0.0% |
| 2023 FY | 22.54 Billion INR | 14.67% |
| 2023 Q3 | 20.57 Billion INR | -2.92% |
| 2023 Q4 | 22.54 Billion INR | 9.53% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 19.65 Billion INR | 7.44% |
| 2022 Q4 | 19.65 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 18.06 Billion INR | 0.0% |
| 2021 Q4 | 18.29 Billion INR | 0.0% |
| 2021 FY | 18.29 Billion INR | 24.08% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 16.62 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 14.74 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 14.74 Billion INR | 25.72% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q2 | 13.18 Billion INR | 0.0% |
| 2019 Q4 | 11.72 Billion INR | 0.0% |
| 2019 FY | 11.72 Billion INR | 49.78% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 7.83 Billion INR | 0.0% |
| 2018 Q4 | 7.83 Billion INR | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 64.45 Billion INR | 65.029% |
| Aurobindo Pharma Limited | 450.71 Billion INR | 94.999% |
| Glenmark Life Sciences Limited | 28.5 Billion INR | 20.921% |
| Granules India Limited | 55.2 Billion INR | 59.172% |
| Indoco Remedies Limited | 21.44 Billion INR | -5.099% |
| Achyut Healthcare Limited | 309.52 Million INR | -7182.476% |
| Ajanta Pharma Limited | 46.38 Billion INR | 51.404% |
| Alkem Laboratories Limited | 155.74 Billion INR | 85.527% |
| Alpa Laboratories Limited | 1.82 Billion INR | -1134.293% |
| Brooks Laboratories Limited | 904.45 Million INR | -2392.207% |
| AstraZeneca Pharma India Limited | 10.78 Billion INR | -109.093% |
| Bajaj HealthCare Limited | 7.65 Billion INR | -194.603% |
| Bliss GVS Pharma Limited | 12.13 Billion INR | -85.694% |
| Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 94.183% |
| Eris Lifesciences Limited | 70.48 Billion INR | 68.022% |
| FDC Limited | 24.68 Billion INR | 8.671% |
| Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 84.302% |
| Gufic Biosciences Limited | 10.92 Billion INR | -106.316% |
| Ind-Swift Laboratories Limited | 11.65 Billion INR | -93.466% |
| Ipca Laboratories Limited | 111.01 Billion INR | 79.695% |
| Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -938.376% |
| Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -1165.099% |
| Lasa Supergenerics Limited | 1.5 Billion INR | -1394.072% |
| Laurus Labs Limited | 83.87 Billion INR | 73.124% |
| Lupin Limited | 239.97 Billion INR | 90.607% |
| Mankind Pharma Limited | 119.63 Billion INR | 81.158% |
| Medicamen Biotech Limited | 2.94 Billion INR | -665.336% |
| Medico Remedies Limited | 961.95 Million INR | -2243.24% |
| Megasoft Limited | 3.65 Billion INR | -516.039% |
| NATCO Pharma Limited | 69.06 Billion INR | 67.362% |
| Piramal Pharma Limited | 153.11 Billion INR | 85.279% |
| RPG Life Sciences Limited | 5.12 Billion INR | -339.504% |
| Sigachi Industries Limited | 6.94 Billion INR | -224.723% |
| Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 97.362% |
| Syncom Formulations (India) Limited | 4.04 Billion INR | -457.027% |
| Unichem Laboratories Limited | 31.69 Billion INR | 28.878% |
| Wanbury Limited | 3.43 Billion INR | -556.225% |
| Windlas Biotech Limited | 6.26 Billion INR | -259.959% |
| ZIM Laboratories Limited | 4.46 Billion INR | -404.47% |
| Zydus Lifesciences Limited | 292.8 Billion INR | 92.302% |
| Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -337.653% |
| Divi's Laboratories Limited | 154.7 Billion INR | 85.429% |
| Hester Biosciences Limited | 6.62 Billion INR | -240.318% |
| Procter & Gamble Health Limited | 7.94 Billion INR | -183.761% |
| Amrutanjan Health Care Limited | 3.66 Billion INR | -514.409% |
| Bal Pharma Limited | 3.2 Billion INR | -603.547% |
| Strides Pharma Science Limited | 58.39 Billion INR | 61.401% |
| Venus Remedies Limited | 6.26 Billion INR | -259.601% |
| Aarti Pharmalabs Limited | 25.82 Billion INR | 12.703% |
| Nectar Lifesciences Limited | 21.91 Billion INR | -2.877% |
| Shilpa Medicare Limited | 30.93 Billion INR | 27.128% |
| Aarti Drugs Limited | 24.32 Billion INR | 7.329% |
| IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | -0.432% |
| Suven Life Sciences Limited | 2.84 Billion INR | -691.178% |
| Ind-Swift Limited | 6.54 Billion INR | -244.413% |
| Valiant Laboratories Limited | 3.42 Billion INR | -557.768% |
| J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 43.565% |
| Solara Active Pharma Sciences Limited | 23.5 Billion INR | 4.121% |
| Themis Medicare Limited | 5.66 Billion INR | -297.956% |
| Hikal Limited | 24.87 Billion INR | 9.37% |
| Torrent Pharmaceuticals Limited | 150.61 Billion INR | 85.034% |
| Sequent Scientific Limited | 15.4 Billion INR | -46.333% |
| Novartis India Limited | 9.24 Billion INR | -143.703% |
| Wockhardt Limited | 76.49 Billion INR | 70.531% |
| Jubilant Pharmova Limited | 115.48 Billion INR | 80.482% |
| Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -4687.505% |
| Neuland Laboratories Limited | 18.32 Billion INR | -23.002% |
| Morepen Laboratories Limited | 12.93 Billion INR | -74.302% |
| Kilitch Drugs (India) Limited | 2.4 Billion INR | -838.962% |
| Mangalam Drugs & Organics Limited | 3.33 Billion INR | -576.042% |